本页面由Tiger Trade Technology Pte. Ltd.提供服务

Medicenna Therapeutics Corp

0.1570
0.0000
成交量:- -
成交额:21.36万
市值:1,093.31万
市盈率:-1.62
高:0.1570
开:0.1570
低:0.1570
收:0.1570
52周最高:0.8388
52周最低:0.1513
股本:6,963.75万
流通股本:4,876.31万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.0971
每股收益(LYR):-0.1147
净资产收益率:-39.00%
总资产收益率:-39.74%
市净率:0.56
市盈率(LYR):-1.37

数据加载中...

2024/05/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/02/21

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/20

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/06/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/23

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/20

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/28

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/05/28

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/07/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans